Clinicopathological and circulating cell‐free DNA profile in myositis associated with anti‐mitochondrial antibody
Annals of Clinical and Translational Neurology · 2023-11 · 10 (11) · 2127-2138
DOI: 10.1002/acn3.51901 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 18.09.2023. Verfasst von Yikang Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Peking University First Hospital, Beijing, 100034, China. Hauptthemen laut MEDLINE: Myositis, Autoimmune Diseases. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park, Beijing Municipal Science and Technology Commission.
Abstract (Originalsprache)
Objective
Anti‐mitochondrial antibodies (AMAs) are associated with idiopathic inflammatory myopathies (IIMs). We aimed to summarize the clinicopathological characteristics, assess circulating cell‐free mitochondrial DNA (ccf‐mtDNA), and circulating cell‐free nuclear DNA (ccf‐nDNA) in AMA‐associated IIMs.
Methods
Medical records of 37 IIMs patients with AMAs were reviewed. Circulating cell‐free mtDNA and ccf‐nDNA levels in sera from IIMs patients with AMAs ( n = 21), disease controls ( n = 66) and healthy controls (HCs) ( n = 23) were measured and compared. Twenty‐eight immune‐mediated necrotizing myopathy (IMNM) patients, 23 dermatomyositis (DM) patients, and 15 anti‐synthetase syndrome (ASS) patients were enrolled as disease controls. Correlations between variables were analyzed.
Results
Limb weakness was observed in 75.7% and neck weakness in 56.8% of patients. Cardiac involvement occurred in 51.4% of patients. Muscle pathology revealed 81.1% of IMNM, 5.4% polymyositis, and 13.5% nonspecific myositis. Microinfarction was observed in 8.1% of patients. Serum ccf‐mtDNA levels in AMA‐associated IIMs were significantly higher than those in HCs ( p < 0.001), but no significant differences between AMA‐associated IIMs and IMNM, DM, or ASS. Serum ccf‐nDNA levels in AMA‐associated IIMs were significantly higher than those in HCs ( p = 0.02), and significantly lower than those in DM ( p = 0.02). Serum ccf‐nDNA levels correlated negatively with MMT8 total scores ( r s = −0.458, p = 0.037) and positively with mRS scores ( r s = 0.486, p = 0.025). Serum ccf‐nDNA levels were significantly higher in the non‐remission group ( p < 0.01).
Interpretation
AMA‐associated IIMs exhibit distinct clinicopathological features. Serum ccf‐nDNA may serve as a potential marker for disease severity and prognosis in AMA‐associated IIMs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Peking University First Hospital, Beijing, 100034, China.
- Beijing Key Laboratory of Neurovascular Disease Discovery, Beijing, 100034, China.
- Key Laboratory for Neuroscience, National Health Commission of the People's Republic of China, Peking University, Beijing, 100083, China.
ORCID-Profile: Yikang Wang, Yawen Zhao, Meng Yu, Zhaoxia Wang
Förderung
- Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park
- Beijing Municipal Science and Technology Commission
Zitieren
APA
Wang, Y., Zhao, Y., Yu, M., Wei, L., Zhang, W., Wang, Z., & Yuan, Y. (2023). Clinicopathological and circulating cell‐free DNA profile in myositis associated with anti‐mitochondrial antibody. Annals of Clinical and Translational Neurology, 10(11), 2127-2138. https://doi.org/10.1002/acn3.51901
Vancouver
Wang Y, Zhao Y, Yu M, Wei L, Zhang W, Wang Z, et al. Clinicopathological and circulating cell‐free DNA profile in myositis associated with anti‐mitochondrial antibody. Annals of Clinical and Translational Neurology. 2023;10(11):2127-2138. doi:10.1002/acn3.51901
BibTeX
@article{Wang2023,
author = {Wang, Yikang and Zhao, Yawen and Yu, Meng and Wei, Luhua and Zhang, Wei and Wang, Zhaoxia and Yuan, Yun},
title = {Clinicopathological and circulating cell‐free DNA profile in myositis associated with anti‐mitochondrial antibody},
journal = {Annals of Clinical and Translational Neurology},
year = {2023},
volume = {10},
number = {11},
pages = {2127--2138},
doi = {10.1002/acn3.51901}
}
EUVIMED